Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17617461 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Pexacerfont for Stress-induced Food Craving
Conditions: Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed;   Placebo
Intervention: Drug: Pexacerfont

Study has passed its completion date and status has not been verified in more than two years.